- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Drug-Eluting Stents in Peru
Total 15 results
-
Johns Hopkins Bloomberg School of Public HealthWashington University School of Medicine; Emory University; University of Georgia and other collaboratorsCompletedSigns and Symptoms, Respiratory | Blood Pressure | Endothelial Function | Respiratory Function Tests | Carotid Intima Media ThicknessPeru
-
Harvard University Faculty of MedicineNational Institute of Allergy and Infectious Diseases (NIAID); Brigham and... and other collaboratorsUnknown
-
University of Cape TownInstitute of Tropical Medicine, Belgium; Epicentre; Medecins Sans Frontieres,... and other collaboratorsRecruitingMulti-drug Resistant TuberculosisVietnam, Kazakhstan, Lesotho, Pakistan, Peru, South Africa
-
Johns Hopkins Bloomberg School of Public HealthBrown University; National Institutes of Health (NIH); Universidad Peruana Cayetano... and other collaboratorsCompletedRespiratory Conditions Due to Other External Agents | Poisoning by Carbon Monoxide From Domestic FuelsKenya, Nepal, Peru
-
Janssen Infectious Diseases BVBAWithdrawnMulti-drug Resistant TuberculosisChina, Ukraine, Taiwan, Korea, Republic of, Peru, Brazil, Estonia, Latvia, Philippines, Russian Federation, South Africa, Thailand, Turkey, Georgia, Mexico, Cambodia, Ethiopia
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLung Cancer | Radiation Toxicity | Drug/Agent Toxicity by Tissue/OrganUnited States
-
Janssen Infectious Diseases BVBACompletedTuberculosisChina, Ukraine, Korea, Republic of, Peru, Estonia, Kenya, Latvia, Philippines, Russian Federation, South Africa, Thailand, Turkey
-
Helsinn Healthcare SAChiltern International Inc.CompletedDrug and/or Toxin-induced DiarrheaUkraine, Germany, Poland, Russian Federation, Belarus, Bulgaria, Hungary, Czechia
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedAnemia | Lung Cancer | Neutropenia | Drug/Agent Toxicity by Tissue/OrganUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedTuberculosis, Pulmonary | Extensively Drug-Resistant Tuberculosis | Tuberculosis, Multidrug ResistantKorea, Republic of, China, United States, Egypt, Estonia, Japan, Latvia, Peru, Philippines
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedBreast Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Drug/Agent Toxicity by Tissue/OrganUnited States
-
SanofiTerminatedAtrial FibrillationSouth Africa, Thailand, Chile, Guatemala, Ukraine, United States, Argentina, Australia, Austria, Belarus, Brazil, Bulgaria, Canada, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Egypt, Estonia, Finland, France, Greece, India, ... and more
-
Crinetics Pharmaceuticals Inc.Active, not recruitingCarcinoid Tumor | Carcinoid Syndrome | Carcinoid | Carcinoid Tumor of Ileum | Carcinoid Tumor of Cecum | Carcinoid Syndrome Diarrhea | Carcinoid Intestine Tumor | Carcinoid Tumor of Liver | Carcinoid Tumor of PancreasUnited States, Brazil, Argentina, Canada, Mexico, Peru, Poland
-
University of South FloridaNational Cancer Institute (NCI)CompletedBreast Cancer | Cardiac ToxicityUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingCardiotoxicity | Recurrent Breast Carcinoma | HER2/Neu Positive | Metastatic Malignant Neoplasm in the Brain | Stage IV Breast Cancer AJCC v6 and v7United States, Korea, Republic of, Puerto Rico, Saudi Arabia